These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32618599)

  • 1. Steatohepatitic Variant of Hepatocellular Carcinoma Is Associated With Both Alcoholic Steatohepatitis and Nonalcoholic Steatohepatitis: A Study of 2 Cohorts With Molecular Insights.
    Qin J; Higashi T; Nakagawa S; Fujiwara N; Yamashita YI; Beppu T; Baba H; Kobayashi M; Kumada H; Gunasekaran G; Schiano TD; Thung SN; Fiel MI; Hoshida Y; Ward SC
    Am J Surg Pathol; 2020 Oct; 44(10):1406-1412. PubMed ID: 32618599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma.
    Kumar R; Goh BG; Kam JW; Chang PE; Tan CK
    Clin Mol Hepatol; 2020 Apr; 26(2):196-208. PubMed ID: 31914720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles of FAT10, FOXO1, and ADRA2A in hepatocellular carcinoma tumorigenesis in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).
    Jia Y; French B; Tillman B; French S
    Exp Mol Pathol; 2018 Aug; 105(1):144-149. PubMed ID: 30009772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The different expression of tumor suppressors, RASSF1A, RUNX3, and GSTP1, in patients with alcoholic steatohepatitis (ASH) vs non-alcoholic steatohepatitis (NASH).
    Jia Y; Ji P; French B; Tillman B; French SW
    Exp Mol Pathol; 2019 Jun; 108():156-163. PubMed ID: 30951700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
    Yeh MM; Liu Y; Torbenson M
    Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steatotic and Steatohepatitic Hepatocellular Carcinomas: Features in a Series With Predominantly Viral Etiology.
    Aykutlu U; Argon A; Orman M; Ulukaya S; Zeytunlu M; Karasu Z; Günşar F; Nart D; Akarca U; Yilmaz F
    Am J Surg Pathol; 2021 Sep; 45(9):1252-1263. PubMed ID: 33826548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging and prognostic characterization of fat-containing hepatocellular carcinoma subtypes.
    Faure A; Dioguardi Burgio M; Cannella R; Sartoris R; Bouattour M; Hobeika C; Cauchy F; Trapani L; Beaufrère A; Vilgrain V; Ronot M
    Radiol Med; 2024 May; 129(5):687-701. PubMed ID: 38512627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate Hepatocellular Carcinoma Screening in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Aby E; Phan J; Truong E; Grotts J; Saab S
    J Clin Gastroenterol; 2019 Feb; 53(2):142-146. PubMed ID: 29912761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcoholic hepatitis versus non-alcoholic steatohepatitis: Levels of expression of some proteins involved in tumorigenesis.
    Nguyen L; Masouminia M; Mendoza A; Samadzadeh S; Tillman B; Morgan T; French B; French S
    Exp Mol Pathol; 2018 Feb; 104(1):45-49. PubMed ID: 29307797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
    Tanaka S; Miyanishi K; Kobune M; Kawano Y; Hoki T; Kubo T; Hayashi T; Sato T; Sato Y; Takimoto R; Kato J
    J Gastroenterol; 2013 Nov; 48(11):1249-58. PubMed ID: 23329365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
    Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
    World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of apoptosis inhibitor of macrophage is a sensitive diagnostic marker for NASH-associated hepatocellular carcinoma.
    Koyama N; Yamazaki T; Kanetsuki Y; Hirota J; Asai T; Mitsumoto Y; Mizuno M; Shima T; Kanbara Y; Arai S; Miyazaki T; Okanoue T
    J Gastroenterol; 2018 Jun; 53(6):770-779. PubMed ID: 29086016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases.
    Stine JG; Wentworth BJ; Zimmet A; Rinella ME; Loomba R; Caldwell SH; Argo CK
    Aliment Pharmacol Ther; 2018 Oct; 48(7):696-703. PubMed ID: 30136293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
    Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features and prognosis of steatohepatitic hepatocellular carcinoma based on varying cutoffs of tumoral steatohepatitic changes.
    Zhang T; Niu N; Taddei T; Jain D; Zhang X
    Am J Clin Pathol; 2024 Oct; ():. PubMed ID: 39418121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.
    Tiniakos DG; Maurício J; Reeves HL
    Adv Exp Med Biol; 2018; 1032():55-69. PubMed ID: 30362090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
    Sadler EM; Mehta N; Bhat M; Ghanekar A; Greig PD; Grant DR; Yao F; Sapisochin G
    Transplantation; 2018 Apr; 102(4):640-647. PubMed ID: 29319620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma with steatohepatitic features: a clinicopathological study of Japanese patients.
    Shibahara J; Ando S; Sakamoto Y; Kokudo N; Fukayama M
    Histopathology; 2014 Jun; 64(7):951-62. PubMed ID: 24898917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.